BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28424417)

  • 1. Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines.
    Breznik B; Motaln H; Vittori M; Rotter A; Lah Turnšek T
    Oncotarget; 2017 Apr; 8(15):25482-25499. PubMed ID: 28424417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin-6 is a novel mediator for the migration of mesenchymal stem cells to glioblastoma cells in response to stromal cell-derived factor-1.
    Park A; Kim SE; Yu J; Son D; Kim KS; Koh E; Park KS
    FEBS Open Bio; 2024 May; ():. PubMed ID: 38719785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5.
    Lah Turnšek T; Jiao X; Novak M; Jammula S; Cicero G; Ashton AW; Joyce D; Pestell RG
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Zebrafish Live Imaging Model Reveals Differential Responses of Microglia Toward Glioblastoma Cells In Vivo.
    Hamilton L; Astell KR; Velikova G; Sieger D
    Zebrafish; 2016 Dec; 13(6):523-534. PubMed ID: 27779463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics.
    Kan P; Srinivasan VM; Gumin J; Garcia R; Chen SR; Johnson JN; Collins DE; Chen MM; Ledbetter D; Huse J; Evan Luna ZA; Robledo A; Vasandani V; Rao A; Singh SK; Shpall EJ; Fueyo J; Gomez-Manzano C; Lang FF
    Neuro Oncol; 2024 Jan; 26(1):127-136. PubMed ID: 37603323
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Oraiopoulou ME; Tzamali E; Tzedakis G; Vakis A; Papamatheakis J; Sakkalis V
    Biomed Res Int; 2017; 2017():8569328. PubMed ID: 29226151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma revisited: from neuronal-like invasion to pacemaking.
    Heuer S; Winkler F
    Trends Cancer; 2023 Nov; 9(11):887-896. PubMed ID: 37586918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drivers of heterogeneity in the glioblastoma immune microenvironment.
    Brosque A; Friedmann-Morvinski D
    Curr Opin Cell Biol; 2023 Dec; 85():102279. PubMed ID: 37984008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
    Shahar T; Rozovski U; Hess KR; Hossain A; Gumin J; Gao F; Fuller GN; Goodman L; Sulman EP; Lang FF
    Neuro Oncol; 2017 May; 19(5):660-668. PubMed ID: 28453745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration.
    Fu Y; Karbaat L; Wu L; Leijten J; Both SK; Karperien M
    Tissue Eng Part B Rev; 2017 Dec; 23(6):515-528. PubMed ID: 28490258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: One step at a time.
    Colmenero J; Sancho-Bru P
    J Hepatol; 2017 Jul; 67(1):7-9. PubMed ID: 28435042
    [No Abstract]   [Full Text] [Related]  

  • 12. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
    Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomaterial-based
    Ahmed T
    Cancer Pathog Ther; 2023 Jul; 1(3):177-194. PubMed ID: 38327839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma research on zebrafish xenograft models: a systematic review.
    Pliakopanou A; Antonopoulos I; Darzenta N; Serifi I; Simos YV; Katsenos AP; Bellos S; Alexiou GA; Kyritsis AP; Leonardos I; Vezyraki P; Peschos D; Tsamis KI
    Clin Transl Oncol; 2024 Feb; 26(2):311-325. PubMed ID: 37400666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells.
    Ah-Pine F; Khettab M; Bedoui Y; Slama Y; Daniel M; Doray B; Gasque P
    Acta Neuropathol Commun; 2023 Jun; 11(1):104. PubMed ID: 37355636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
    Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
    Zottel A; Novak M; Šamec N; Majc B; Colja S; Katrašnik M; Vittori M; Hrastar B; Rotter A; Porčnik A; Lah Turnšek T; Komel R; Breznik B; Jovčevska I
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting the focus of zebrafish toward a model of the tumor microenvironment.
    Weiss JM; Lumaquin-Yin D; Montal E; Suresh S; Leonhardt CS; White RM
    Elife; 2022 Dec; 11():. PubMed ID: 36538362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.